Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-09-10

FDA Approved: GVOKE HYPOPEN 0.5 MG AUTO-INJECTOR — Original Application (Xeris Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved GVOKE HYPOPEN 0.5 mg Auto-Injector (glucagon injection, solution) from Xeris Pharmaceuticals in an original application (NDA212097) for the emergen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GVOKE HYPOPEN 0.5 MG AUTO-INJECTOR (GLUCAGON INJECTION, SOLUTION)

Snippet

ORIG AP for GVOKE HYPOPEN 0.5 MG AUTO-INJECTOR (GLUCAGON INJECTION, SOLUTION)